Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin in Amnestic MCI
NCT00842920Phase 4Unknown
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Dec 2008
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of simvastatin in Mild Cognitive Impairment (MCI) (3 arms), sponsored by Charité – Universitätsmedizin Berlin. Primary endpoint: Clinical Dementia Rating - Sum of Boxes at 24 months. Status: unknown.
02
Drugs
simvastatin
03
Conditions
Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on NCT00842920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00842920.